Liangren Zhang

机构：Peking University, State Key Laboratory of Natural and Biomimetic Drugs · ORCID：0000-0002-7362-9497

发表论文 296 篇 · 总被引 8011 次 · h-index 45

代表论文

• Deep-Learning-Driven Discovery of SN3–1, a Potent NLRP3 Inhibitor with Therapeutic Potential for Inflammatory Diseases (2024 · Journal of Medicinal Chemistry · 被引 13)
• Novel mechanistic insights – A brand new Era for anti-HBV drugs (2024 · European Journal of Medicinal Chemistry · 被引 11)
• MTHFD2: A significant mitochondrial metabolic enzyme and a novel target for anticancer therapy (2025 · Drug Discovery Today · 被引 7)
• Discovery of Potent and Selective Blockers Targeting the Epilepsy-Associated K Na 1.1 Channel (2024 · Journal of Medicinal Chemistry · 被引 5)
• Low-molecular-weight dextran sulfate sodium as novel heparanase inhibitor preventing breast cancer metastasis in mice by inhibiting migration and angiogenesis (2025 · Carbohydrate Polymers · 被引 4)
• The frameshifting element in coronaviruses: structure, function, and potential as a therapeutic target (2025 · Trends in Pharmacological Sciences · 被引 4)